Search This Blog

Thursday, April 30, 2020

ResMed EPS beats by $0.21, beats on revenue

ResMed (NYSE:RMD): Q3 Non-GAAP EPS of $1.29 beats by $0.21; GAAP EPS of $1.12 beats by $0.14.
Revenue of $769.46M (+16.2% Y/Y) beats by $48.04M.
Shares +1.08%.
Press Release
https://seekingalpha.com/news/3567205-resmed-eps-beats-0_21-beats-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)